Intervention Review

Ziprasidone versus other atypical antipsychotics for schizophrenia

  1. Katja Komossa1,*,
  2. Christine Rummel-Kluge1,
  3. Heike Hunger1,
  4. Sandra Schwarz1,
  5. Paranthaman Sethupathi Bhoopathi2,
  6. Werner Kissling1,
  7. Stefan Leucht1

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 29 APR 2007

DOI: 10.1002/14651858.CD006627.pub2

How to Cite

Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, Bhoopathi PS, Kissling W, Leucht S. Ziprasidone versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD006627. DOI: 10.1002/14651858.CD006627.pub2.

Author Information

  1. 1

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  2. 2

    Coimbatore(Dt) Tamilnadu, India

*Katja Komossa, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Moehlstrasse 26, München, 81675, Germany. k.komossa@lrz.tu-muenchen.de.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

  1. Current Version

    Ziprasidone versus other atypical antipsychotics for schizophrenia

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Sandra Schwarz, Paranthaman Sethupathi Bhoopathi, Werner Kissling and Stefan Leucht

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD006627.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Ziprasidone versus other atypical antipsychotics for schizophrenia

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmidt, Sandra Schwarz, Paranthaman Seth S Bhoopathi and Stefan Leucht

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD006627